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A survey of the blood of twenty-two patients who had undergone hepatic resection was performed.
Serum levels of a-2 plasmin inhibitor-plasmin complex initially decreased from 1.58 + 0.31/g/ml on the
preoperative day (PREOP), to 0.92 _+ 0.14/dml on the first postoperative day (POD 1), and then
increased to 3.13 + 0.92 /g/ml on the seventh postoperative day (POD 7) (mean + SE)).
Thrombin-anti-thrombin III complex (14.2 + 4.3 ng/ml on PREOP and 26.0 + 4.1 ng/ml on POD 7
(mean + SE)) and D-dimer (335 + 96 ng/ml on PREOP and 1859 + 258 ng/ml on POD 7 (mean +
SE)) increased in the early postoperative stage. The level of 6-keto-prostaglandin Fla increased after
the operations (from 13.2 _+ 1.8 pg/ml on PREOP to 37.8 + 12.8 pg/ml on POD 7 (mean + SE)). The
level of thromboxane B-2 decreased at first, and then gradually increased and returned to its
preoperative level on POD 7 (144.7 + 43.8 pg/ml on PREOP, 57.6 + 27.5 pg/ml on POD and 152.5
+ 58.4 pg/ml on POD 7 (mean + SE)). Superoxide dismutase activity increased at first, and then
gradually decreased, postoperatively (2.8 + 0.5 NU/ml on PREOP, 4.8 _+ 0.8 NU/ml on POD and 2.6
+ 0.3 NU/ml on POD 7 (mean + SE)). That is, biodefensive reactions which protect patients against
the shift to disseminated intravascular coagulation (DIC) were inferred with by the increase in anti-
platelet aggregation, despite the activation of coagulation and fibrinolytic mechanisms after hepatic
resection.
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INTRODUCTION
Disseminated intravascular coagulation (DIC) is a life-threatening, hemorrhagic
state where the activation of coagulation and the subsequent activation of fibrinoly-
sis occur.
It is safe to say that patients on whom hepatectomies have been performed are in
the predisseminated intravascular coagulation state because of hypercoagulation
and hyperfibrinolysis after the hepatectomy. Coagulation, fibrinolysis, platelet
aggregation, liver regenerative and liver destructive factors are related to the
occurrence of DIC.
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This paper describes serological changes after a hepatectomy through the
measurement of serial levels of several substances that behave as coagulating or
fibrinolytic factors, platelet aggregation regulators or that correlate with liver
regeneration and destruction in plasma before and after hepatic resection.
PATIENTS AND METHODS
Twenty-two patients underwent liver resections at Kyoto Prefectural University of
Medicine Hospital between July 1989 and January 1990. There were 16 men and 6
women. Their ages ranged from 40 to 77 years with a median of 62 years. They
were classified by diseases" 12 patients had hepatocellular carcinomas, 6 had
metastatic liver cancer, and 4 had malignant biliary tumors. Ten patients had liver
cirrhosis and 12 did not. Hepatectomies or further resections were performed on 7
patients, 3 ofwhom had cirrhotic livers. Segmentectomies were done on 3 patients,
one of whom was cirrhotic. Six patients, all having liver cirrhosis, underwent
subsegmentectomies. Six patients underwent partial resections, two of whom were
cirrhotic. The median of operating time was 285 minutes, with a range of 130 to 516
minutes. The median of blood loss was 1241 grams, with a distribution from 300 to
6021 grams. The median requirement for blood transfusion was 0 units and the
average was 3.1 units, with a maximum of 11.5 units. Seven patients received 0.5 to
1.5 units of fresh whole blood. The rest of the transfused blood was concentrated
red cells (CRC). The median of fresh frozen plasma (FFP) used was 5 units, with a
maximum of 22 units.
Blood samples were taken from these patients before their operations, on
postoperative day (POD) 1, POD 3 and POD 7, and then divided to measure
prothrombin time (PT), plasma fibrinogen, serum fibrinogen/fibrin degradation
products (FDP) (normal value < 5 /g/ml), serum thrombin-anti-thrombin III
complex (TAT), serum a2-plasmin inhibitor-plasmin complex (PIC), serum
D-dimer (DD), serum 6-keto-prostaglandin Fla (6-keto-PGla), serum thrombox-
ane B-2 (TXB2), serum superoxide dismutase (SOD) activity and serum prostag-
landin E2 (PGE2). Serum total bilirubin, serum glutamic oxalacetic transaminase
(S-GOT), serum glutamic pyruvic transaminase (S-GPT), platelet count, and the
preoperative value of the 15 minute indocyanine green retention test (ICG R15), a
parameter related to liver function, was also measured.
PT (normal values: 80-110%) was measured by Quick’s test and indicated as
prothrombin index. Plasma fibrinogen (normal values: 200-400 mg/dl) was mea-
sured using thrombin time. FDP was measured by latex fixation test. TAT (normal
value < 3.0 ng/ml) was measured by enzyme-linked immunosorbent assay
(ELISA) using Enzygmost-TAT (Hoechst Japan Co. Japan). PIC (normal value <
0.8/g/ml) was tested by the enzyme immunoassay (EIA) method using a2-PI
complex "Teijin" EIA-B (Teijin Co. Japan). DD (normal value < 150 ng/ml) was
assayed by ELISA using DIMERTEST EIA (Fuji Repio Co. Japan). 6-keto-
PGFla (normal values: 12-33 pg/ml), TXB2 (normal values: 14-50 pg/ml) and
PGE2 (normal values < 8.4 pg/ml in males and < 4.4 pg/ml in females) were
measured by radioimmunoassay (RIA). SOD activity (normal value < 21 NU/ml)
was determined by the nitrate-kit method (Fujisawa Pharmaceutical Co. Japan).
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RESULTS
The mean preoperative value of ICG R15 was 19.0%. The mean serum total
bilirubin level on the preoperative day (PREOP), POD 1, POD 3, and POD 7 was
0.9, 2.0, 1.7, and 1.0 mg/dl, respectively. The mean serum GOT level on PREOP,
POD 1, POD 3, and POD 7 was 40.4, 146.9, 160.4, 43.4 Karmen Unit (KU),
respectively. The mean serum GPT level on PREOP, POD 1, POD 3, and POD 7
was 26.3, 82.0, 96.9, 36.5 KU, respectively. Mean PT value on PREOP, POD 1,
POD 3, and POD 7 was 97.6, 91.9, 104.6, 96.7%, respectively. The mean plasma
fibrinogen level on PREOP, POD 1, POD 3, and POD 7 was 310.6, 308.5,534.4,
403.4 mg/dl, respectively, and the value for POD 3 was significantly higher than the
value for POD 1 (p < 0.005). The mean serum FDP level on PREOP, POD 1,
POD 3, and POD 7 was 4.49, 9.36, 17.94, 22.9 pg/ml, respectively, and no
statistically significant difference was noted between the values on POD 1 and POD
3. The mean platelet count on PREOP, POD 1, POD 3, and POD 7 was 229000,
180000, 198000, 247000, respectively. The serum TAT level on PREOP, POD 1,
POD 3, and POD 7 was 14.2 + 4.3, 27.4 + 4.0, 29.8 + 4.1, 26.0 + 4.1 ng/ml
(mean + standard error (SE)), respectively (Figure 1). The serum PIC level on
PREOP, POD 1, POD 3, and POD 7 was 1.58 + 0.31, 0.92 + 0.14, 4.45 + 1.86,














Figure 1 The levels of serum thrombin-antithrombin III complex (TAT), a-2 plasmin inhibitor-
plasmin complex (PIC) and D-dimer (DD) increased in the first operative week. Each value is the mean
+ standard error (SE).46 A. OGURO ET AL.
on PREOP, POD 1, POD 3, and POD 7 was 335 _+ 96.5,820 _+ 175.3, 1472 +
290.0, 1859 +_ 257.7 ng/ml (mean + SE), respectively (Figure 1). Both PIC and
DD levels tended to increase postoperatively. The serum 6-keto-PGFla level on
PREOP, POD 1, POD 3, and POD 7 was 13.2 _+ 1.8, 21,2 + 3.7, 23.4 + 4.2, 37.8
+ 12.8 pg/ml (mean + SE), respectively, and the value tended to increase
postoperatively. The serum TXB2 level on PREOP, POD 1, POD 3, and POD 7
was 144.7 + 43.8, 57.6 _+ 27.5, 79.1 + 27.2, 152.5 + 58.4 pg/ml (mean + SE),
respectively (Figure 2). It can be seen that the value decreased on POD 1, and then
recovered. The serum SOD activity level on PREOP, POD 1, POD 3, and POD 7
was 2.8 _+ 0.5, 4.8 + 0.8, 3.8 _+ 0.7, 2.6 _+ 0.3 NU/ml (mean _+ SE), respectively.
SOD activity peaked on POD 1 and subsequently decreased gradually. The serum
PGE2 level on PREOP, POD 1, POD 3, and POD 7 was 4.5 + 0.7, 3.4 +_ 0.4, 5.7
_+ 1.3, 16.1 + 8.4 pg/ml (mean +_ SE), respectively, and the value exhibited a
tendency to increase postoperatively.
There was, in this small group of 22 patients, no significant difference, either
between patients with or without liver cirrhosis, or among patients who had
undergone different types of liver resections, with regard to serum TAT, PIC, DD,
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Figure 2 The level of serum 6-keto-prostaglandin Fla (6-keto-PGFla) gradually increased after
hepatic resection. The level of serum Thromboxane B-2 (TXB2) decreased on postoperative day 1, and
then returned to its preoperative range within one week. Each value is the mean + standard error (SE).BLOOD STUDY AFTER LIVER RESECTION 47
DISCUSSION
DIC is a syndrome which is characterised by extended intravascular coagulation
with consumption of coagulation factors and pathological overactivation of the
fibrinolysis, leading to an increased tendency to bleed. Diseases often implicated as
triggers of DIC include malignant tumors, leukemia and sepsis.
In surgery, the activation of blood coagulation is inevitable and reticuloendothe-
lial system hypofunction, or shock state, easily occurs. Therefore, it can be said that
postoperative patients are in the pre-DIC state. Especially for a hepatic resection,
postoperative DIC cannot be ignored because it is assumed that the remnant liver is
unable to remove active coagulation factors released by extensive liver resection
and massive blood transfusion. Moreover, Almersjoe et al. reported that the
coagulation defect occurs after extensive liver resection2. In that regard Tsuzuki
and his associates reported that the incidence of DIC correlated with the extent of
hepatic resection or blood loss. Patients in whom of two or more segments of the
liver were resected, or more than 4000g of blood was lost had a statistically higher
incidence of DIC3. Bengmark et al. found that in rats, defects in hemostasis were
produced by antibiotics after liver resection4. In the present study, 7 patients
underwent hepatectomies or further resections and 2 patients lost more than 4000g
of blood. However, neither these 9 patients nor any of the other 13 patients needed
a transfusion of platelets, or the administration of anti-thrombin III or heparin.
During the course of blood coagulation thrombin is produced in blood, and is
presumed to quickly form a complex with anti-thrombin III. Therefore the measure-
ment of TAT has the same significance as obtaining the blood value of thrombin,
which cannot be detected directly. The serum TAT level increase in cases of disease
accompanied by hypercoagulation, DIC, malignant tumors, pulmonary embolism
and phlebothrombosis. Thus, TAT plays a role in the detection of hypercoagula-
tion and DIC5-7. Plasmin, which is regarded as the one of the most important
fibrinolytic factors, has so short a half-life that it cannot be measured. However,
a2-plasmin inhibitor, which is the most important plasmin inhibitor, instantly
inhibits plasmin which has just been produced. Thus, the formation of PIC reflects
the production of plasmin. The detection of an increase of PIC in the blood is useful
in the diagnosis of DIC in its early stages. Quantification of PIC and a study of the
behavior of the a2-plasmin inhibitor have been performed8’9. Fibrinogen/fibrin
degradation product (FDP) consists of several fragments, and in normal fibrinoge-
nolysis, the D fragment forms monomers. On the other hand, cross-linked fibrin
produces DD during proteolysis. Therefore DD can be found only during second-
ary fibrinolysis, and thus its measurement is useful for the diagnosis of DIC,
including DIC in its early phase. DD and its surroundings have been studied
previously1’11. In this study, although PIC had an initial decrease, the level of not
only TAT, but also DD, increased in the postoperative seven days. Some patients
may be in the pre-DIC state after hepatic resection because coagulation and
fibrinolysis progress simultaneously.
Thromboxane A-2 (TXA2) promotes platelet aggregation, and its stable metabo-
lite, TXB2, provides a good indication of the TXA2 concentration12’13.
Prostaglandin I2 (PGI2) inhibits platelet aggregation by acting antagonistically to
TXA2, and the stable metabolite of PGI2, 6-keto-PGFla, is usually measured to
assess the rate of PGI2 synthesis12. In this study, the level of 6-keto-PGFla48 A. OGURO ET AL.
increased after the hepatectomies whereas the TXB2 level decreased initially, then
increased gradually and finally returned to its preoperative value on POD 7.
However, the results do not establish the presence of anti-aggregatory activity
because PGI2 production did not proceed in the absence of platelet adhesion or
aggregation in oioo.
SOD eliminates superoxides, which are regarded as DIC-aggravating
substances14. Moreover SOD may be considered platelet inhibitor because
Parnham et al. reported that platelet activating factor induced the oxidative burst in
guinea-pig macrophages15. In this study the SOD activity increased at first, and then
decreased gradually after the operation but against our expectation, its value
always remained within normal range. Involvement of prostaglandins in liver
regeneration after a partial hepatectomy has been suggested
16 and the possibility
that PGE2 and prostaglandin F2a (PGF2a) are liver regeneration factors has been
reported17. Furthermore, a possible role of PGE2 as platelet inhibitor18’19 and
fibrinolytic activator2 has been suggested. Though the serum SOD activity
remained within its normal value, the possibility was suggested that, in the pre-DIC
state, the production of SOD increased in order to eliminate free radicals and that
the aggravation of DIC progressed until the elimination of free radicals was
completed. Similarly, the production of PGE2 increased in order to promote liver
regeneration after hepatic damage.
It is thought that because of the decrease of coagulating function due to
hyposynthesis in patients with liver cirrhosis, hypocoagulation after hepatic resec-
tion may occur and DIC is more likely to occur than in patients without liver
cirrhosis. However, in this study no significant differences between the cirrhotic
group and the non-cirrhotic one were found in serum TAT, PIC, DD, 6-keto-
PGla, TXB2, PGE2 or in SOD activity. This may be due to the efficacy of
postoperative intensive care, the administration of FFP, liver protective therapy,
restriction of water intake, etc. which could have prevented DIC from occurring. In
order to prevent pneumonia during postoperative intensive care, patients were
encouraged to refrain from lying down for long periods and epidural anesthesia was
used for the peri- and postoperative periods. In order to prevent bleeding from the
GI-tract, H2-receptor antagonist, sulpiride, aluminium hydroxide gel and magne-
sium hydroxide were administered postoperatively. Furthermore, it is important to
decide on the extent of hepatic resection in proportion to liver function, and to
reduce blood loss as much as possible.
In conclusion, the activation of coagulation and fibrinolytic mechanisms may be
induced after hepatic resection. However, this state may be improved by an
increase in anti-platelet aggregation. We inferred the existence of biodefensive
reactions which protect patients against the shift to DIC.
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